PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma is a research paper published in Scientific Reports (2021). On theSindex it has a DataRank of 0.385. It has been cited 12 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.385
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: T32 CA229102
National Institutes of Health
Grant: T32 CA091078
National Institutes of Health
Grant: T32 CA183926
National Institutes of Health
Grant: 5T32CA229102-08
Surgical Oncology Research Training Program
National Institutes of Health
Grant: 5T32CA183926-02
Research Training Program in Basic and Translational Oncology
National Institutes of Health
Grant: 5T32CA091078-08
Research Training Program in Surgical Oncology
Open Hands Overflowing Hearts
Starr Fund-Vince Lombardi Cancer Foundation
Elaine Roberts Foundation
Cannonball Kids’ cancer
Sid Strong Foundation
Society of University Surgeons
FWCI
1.00
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals